Impaired PI3K/Akt Signaling as a Potential Cause of Failure to Precondition Rat Hearts Under Conditions of Simulated Hyperglycemia
Authors:
- M. ZálešákMZM. Zálešák
- P. BlažíčekPBP. Blažíček
- I. GablovskýIGI. Gablovský
- V. LedvényiováVLV. Ledvényiová
- M. BartekováMBM. Barteková
- A. ZiegelhöfferAZA. Ziegelhöffer
- T. RavingerováTRT. Ravingerová
- 16 October 2015
- journal article
- Published by Institute of Physiology of the Czech Academy of Sciences in Physiological Research
- Vol. 64 (5) , 633-641
Abstract
The aim of the study was to evaluate the impact of simulated acute hyperglycemia (HG) on PI3K/Akt signaling in preconditioned and non-preconditioned isolated rat hearts perfused with Krebs-Henseleit solution containing normal (11 mmol/l) or elevated (22 mmol/l) glucose subjected to ischemia-reperfusion. Ischemic preconditioning (IP) was induced by two 5-min cycles of coronary occlusion followed by 5-min reperfusion. Protein levels of Akt, phosphorylated (activated) Akt (P-Akt), as well as contents of BAX protein were assayed (Western blotting) in cytosolic fraction of myocardial tissue samples taken prior to and after 30-min global ischemia and 40-min reperfusion. In “normoglycemic” conditions (NG), IP significantly increased P-Akt at the end of long-term ischemia, while reperfusion led to its decrease together with the decline of BAX levels as compared to non-preconditioned hearts. On the contrary, under HG conditions, P-Akt tended to decline in IP-hearts after long-term ischemia, and it was significantly higher after reperfusion than in non-preconditioned controls. No significant influence of IP on BAX levels at the end of I/R was observed under HG conditions. It seems that high glucose may influence IP-induced activation of Akt and its downstream targets, as well as maintain persistent Akt activity that may be detrimental for the heart under above conditions.Keywords
This publication has 43 references indexed in Scilit:
- Interaction of Risk Factors, Comorbidities, and Comedications with Ischemia/Reperfusion Injury and Cardioprotection by Preconditioning, Postconditioning, and Remote ConditioningPharmacological Reviews, 2014
- Insulin suppresses ischemic preconditioning-mediated cardioprotection through Akt-dependent mechanismsJournal of Molecular and Cellular Cardiology, 2013
- Delayed cardioprotective effects of WY-14643 are associated with inhibition of MMP-2 and modulation of Bcl-2 family proteins through PPAR-α activation in rat hearts subjected to global ischaemia–reperfusionCanadian Journal of Physiology and Pharmacology, 2013
- Kinases and phosphatases in ischaemic preconditioning: a re-evaluationBasic Research in Cardiology, 2010
- Interaction of Cardiovascular Risk Factors with Myocardial Ischemia/Reperfusion Injury, Preconditioning, and PostconditioningPharmacological Reviews, 2007
- Signaling pathways in ischemic preconditioningHeart Failure Reviews, 2007
- PARADOXICALLY ENHANCED HEART TOLERANCE TO ISCHAEMIA IN TYPE 1 DIABETES AND ROLE OF INCREASED OSMOLARITYClinical and Experimental Pharmacology and Physiology, 2006
- New directions for protecting the heart against ischaemia–reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathwayCardiovascular Research, 2004
- The prognostic significance of angina pectoris preceding the occurrence of a first acute myocardial infarction in 4166 consecutive hospitalized patientsAmerican Heart Journal, 1992
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976